University of Pittsburgh
Pittsburgh, Pennsylvania, 15216, United States
NCT Number: NCT01982877
The purpose of this study is to test the effectiveness of a multi-faceted communication intervention for family members of critically ill patients to reduce the family members' long-term symptoms of depression and anxiety.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15216, United States
One in four elderly Americans die in or shortly after discharge from an intensive care unit. An expanding body of literature documents that physician-family communication and end-of-life care is poor in intensive care units. These deficiencies are associated with high rates of adverse psychological outcomes among surrogates, physician-family conflict, and life support decisions that may be inconsistent with patients' goals and preferences. There is a lack of information on practical, generalizable interventions that effectively improve this important aspect of care for elderly patients and their families.
The primary aim of this study is to evaluate the effectiveness of a multifaceted communication intervention as compared to an educational control to improve psychological outcomes among family members of critically ill patients, using a randomized, controlled trial design.
This randomized controlled trial involves adding a Family Support Specialist (FSS) to the clinical team to provide four types of support to the families of patients with advanced critical illness: emotional support, communication support (between the clinical team and the family), decisional support (education about the role of a surrogate decision maker) and anticipatory grief support.
The overall aim of the study is to improve the long-term psychological outcomes for family members of critically ill patients, to improve the quality of communication and decision-making between physicians and families, and to improve the patient-centeredness of care.
What happens in the study?
Patient is randomized to one of two groups:
What do participants need to do?
Family Members: Interact with the Family Support Specialist daily. Family Support Specialist addresses family needs and ensures that their questions are addressed.
Physicians: Collaborate with the Family Support Specialist to determine how best to support the family as well as attending clinician-family meetings.
Sample size: With a sample size of 300 patients (450 surrogates), the study is well powered to detect small and clinically important differences in the primary outcome measure Hospital Anxiety and Depression Score (HADS).The trial's original sample size of 400 patients (600 surrogates) was chosen to maximize the power to detect differences in a secondary outcome measure (costs) that required a substantially larger sample size than the primary outcome (HADS). Since the original power calculations were conducted, new data were published which indicated that cost analysis in this context will require an even larger sample size based one effect modification from whether the patient lived or died. Therefore, the Data and Safety Monitoring Board recommended revising the sample size to power the trial on the primary outcome (HADS), which required 300 patients (450 surrogates).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patient Inclusion criteria:
Patient Exclusion Criteria:
Surrogate Inclusion criteria:
Surrogate Exclusion Criteria:
Physician Inclusion criteria:
Physician Exclusion Criteria:
The Four Supports Intervention is a multi-faceted intervention involving the addition of a trained nurse/social worker interventionist to the patient's care team who delivers four kinds of support: emotional support, communication support, decision support, and anticipatory grief support.
In addition to usual care, enrolled surrogates will receive two 15-minute education sessions about critical illness and mechanical ventilation on days 2 and 5, delivered by a research staff coordinator with education in critical care nursing.
Time frame: participants will be followed six months following the patient's death or discharge from hospital, an expected average of 195 days
Burden of anxiety and depression will be measured in family members 6 months after enrollment using the validated 14-item Hospital Anxiety and Depression scale (HADS).
Time frame: At 6 months
Patient and family-centeredness of care measured using the 12-item Patient-Perceived Patient-Centeredness of Care Scale (PPPC) adapted to use by surrogates.
Time frame: Duration of hospital stay, an expected average of 4 weeks
he costs are measured using aggregate data form the date of hospital admission through hospital discharge
Time frame: Participants will be followed for duration of ICU stay, an expected average of 21 days
The Intensive Care Unit length of stay , assessed by abstraction from hospital administrative records
Time frame: Participants will be followed for duration of hospital stay, an expected average of 4 weeks
Hospital length of stay length of stay , assessed by abstraction from hospital administrative records
Time frame: at 6 months
Symptoms of post traumatic stress in family members assessed using the validated 22 item Impact of Events Scale.
Time frame: Participants are followed at time of enrollment, on day 5 of enrollment, and weekly thereafter for the duration of the hospital stay, an expected average of 4 weeks
Prognostic estimates of survival and long-term functional impairment are measured responses by assessing the surrogate decision maker and the physician
Time frame: Participants are followed at time of enrollment and on day 5 of enrollment
This validated instrument measures personal perceptions of:
Time frame: Day 5 of enrollment
Quality of communication in family members is assessed using the validated 19 item Quality of Communication Scale
Time frame: at 3 months
Symptoms of post traumatic stress in family members assessed using the validated 22 item Impact of Events Scale.
Time frame: At 3 months and at 6 months
This validated instrument consists of 19 first-person statements concerning the immediate bereavement-related thoughts and behaviors of the participant.
Time frame: At 3 months and 6 months
The utilization of mental health treatment is tracked via participant interview
Time frame: At 6 months
Functional status of the patient is assessed using the validated Katz Activities of Daily Living Scale.
Time frame: At 6 months
Mortality of the patient will be assessed at 6 months using hospital administrative records, and the 6-month follow-up with surrogate decision makers.
Time frame: Participants will be followed for duration of hospital stay, an expected average of 4 weeks
The disposition of the patient at time of discharge will be assessed via chart abstraction
Time frame: at 3 months
Hospital Anxiety and Depression Scale
University of Pittsburgh
Other
A Trial to Improve Surrogate Decision-Making for Critically Ill Older Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07005258
Candida, Critically Ill Intensive Care Unit Patients
Vandœuvre-lès-Nancy, Lorraine, France
View Trial DetailsNCT07732114
Critically Ill Intensive Care Unit Patients
Alexandria, Shebin El-Kom, Egypt
View Trial DetailsNCT07640633
Critically Ill Intensive Care Unit Patients, Feeding Intolerance
Wuhan, Hubei, China
View Trial DetailsNCT07093203
Abdominal Surgery Patients, Candida
Vandœuvre-lès-Nancy, Lorraine, France
View Trial Details